446 related articles for article (PubMed ID: 20403950)
1. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.
Ierardi AM; Mangini M; Vaghi M; Cazzulani A; Carrafiello G; Mattassi R
Vasc Endovascular Surg; 2010 May; 44(4):282-8. PubMed ID: 20403950
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
Spence J; Krings T; TerBrugge KG; Agid R
Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
[TBL] [Abstract][Full Text] [Related]
3. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study.
Andreisek G; Nanz D; Weishaupt D; Pfammatter T
J Vasc Interv Radiol; 2009 Jul; 20(7):879-87. PubMed ID: 19481473
[TBL] [Abstract][Full Text] [Related]
4. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
[TBL] [Abstract][Full Text] [Related]
5. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
6. Absolute ethanol sclerotherapy for venous malformations in the face and neck.
Su L; Fan X; Zheng L; Zheng J
J Oral Maxillofac Surg; 2010 Jul; 68(7):1622-7. PubMed ID: 19962811
[TBL] [Abstract][Full Text] [Related]
7. Ethanol sclerotherapy of superficial venous malformation: a new procedure.
Orlando JL; Caldas JG; Campos HG; Nishinari K; Wolosker N
Dermatology; 2010; 220(4):376-80. PubMed ID: 20484881
[TBL] [Abstract][Full Text] [Related]
8. Ethanol sclerotherapy of peripheral venous malformations.
Rimon U; Garniek A; Galili Y; Golan G; Bensaid P; Morag B
Eur J Radiol; 2004 Dec; 52(3):283-7. PubMed ID: 15544907
[TBL] [Abstract][Full Text] [Related]
9. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of facial paralysis caused by ethanol sclerotherapy for facial venous malformation.
Hu X; Chen D; Jiang C; Jin Y; Chen H; Ma G; Lin X
Head Neck; 2011 Nov; 33(11):1616-21. PubMed ID: 21990226
[TBL] [Abstract][Full Text] [Related]
11. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
Odeyinde SO; Kangesu L; Badran M
J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):215-23. PubMed ID: 23059134
[TBL] [Abstract][Full Text] [Related]
12. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
Jin Y; Lin X; Li W; Hu X; Ma G; Wang W
J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776
[TBL] [Abstract][Full Text] [Related]
13. Digital subtraction angiography-guided foam sclerotherapy of peripheral venous malformations.
Li L; Zeng XQ; Li YH
AJR Am J Roentgenol; 2010 May; 194(5):W439-44. PubMed ID: 20410391
[TBL] [Abstract][Full Text] [Related]
14. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck.
Lee CH; Chen SG
Br J Plast Surg; 2005 Dec; 58(8):1073-8. PubMed ID: 16055097
[TBL] [Abstract][Full Text] [Related]
15. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
Li L; Feng J; Zeng XQ; Li YH
J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
[TBL] [Abstract][Full Text] [Related]
16. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation.
Lee BB; Kim DI; Huh S; Kim HH; Choo IW; Byun HS; Do YS
J Vasc Surg; 2001 Apr; 33(4):764-72. PubMed ID: 11296330
[TBL] [Abstract][Full Text] [Related]
17. Treatment of venous malformations: first experience with a new sclerosing agent--a multicenter study.
Schumacher M; Dupuy P; Bartoli JM; Ernemann U; Herbreteau D; Ghienne C; Guibaud L; Loose DA; Mattassi R; Petit P; Rössler JK; Stillo F; Weber J
Eur J Radiol; 2011 Dec; 80(3):e366-72. PubMed ID: 21458186
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and complications of sclerotherapy for venous malformations.
Qiu Y; Chen H; Lin X; Hu X; Jin Y; Ma G
Vasc Endovascular Surg; 2013 Aug; 47(6):454-61. PubMed ID: 23759722
[TBL] [Abstract][Full Text] [Related]
19. Sclerotherapy in venous malformation.
Rabe E; Pannier F
Phlebology; 2013 Mar; 28 Suppl 1():188-91. PubMed ID: 23482557
[TBL] [Abstract][Full Text] [Related]
20. Sodium tetradecyl sulphate direct intralesional sclerotherapy of venous malformations of the vulva and vagina: report of five cases.
Krokidis M; Venetucci P; Hatzidakis A; Iaccarino V
Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S228-31. PubMed ID: 20559638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
